JAGUAR HEALTH, INC. Payments for (Proceeds from) Deposit on Loan
JAGUAR HEALTH, INC. (JAGX) reported Payments for (Proceeds from) Deposit on Loan of $3.00 million for the 9-month period ending 2017-09-30, per its 10-K filed 2018-04-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromDepositOnLoan · last filed 2018-04-09
- JAGUAR HEALTH, INC. payments for (proceeds from) deposit on loan for the quarter ending 2017-09-30 was $0.00.
- JAGUAR HEALTH, INC. payments for (proceeds from) deposit on loan for the quarter ending 2017-06-30 was $21.19K.
- JAGUAR HEALTH, INC. payments for (proceeds from) deposit on loan for the quarter ending 2017-03-31 was $2.98M.
- JAGUAR HEALTH, INC. payments for (proceeds from) deposit on loan for the quarter ending 2016-12-31 was $400.00K.
- JAGUAR HEALTH, INC. payments for (proceeds from) deposit on loan for fiscal 2016 was $2.50M.
| Period end | Payments for (Proceeds from) Deposit on Loan | Payments for (Proceeds from) Deposit on Loan 3 month | Payments for (Proceeds from) Deposit on Loan 6 month | Payments for (Proceeds from) Deposit on Loan 9 month | Payments for (Proceeds from) Deposit on Loan 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2018-04-09 | $21.19K derived: sum of 2 quarters · filed 2018-04-09 | $3.00M 10-K · filed 2018-04-09 | $3.40M derived: sum of 4 quarters · filed 2018-04-09 | |
| 2017-07-07 | $1.00M 10-K · filed 2018-04-09 | ||||
| 2017-06-30 | $21.19K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | $3.00M 10-Q · filed 2017-08-09 | $3.40M derived: sum of 3 quarters · filed 2017-08-09 | ||
| 2017-03-31 | $2.98M 10-Q/A · filed 2017-06-23 | $3.38M derived: sum of 2 quarters · filed 2017-06-23 | |||
| 2016-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $2.50M 10-K · filed 2017-02-15 | |||
| 2016-09-30 | $2.10M 10-Q · filed 2016-11-14 | ||||
| 2016-04-21 | $1.50M 10-Q · filed 2017-11-20 | ||||
| 2016-04-01 | $176.96K 10-Q · filed 2016-08-15 | ||||
| 2016-03-01 | $178.74K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |